News June 24, 2021 - Glycomine Closes $68 Million Series B to Advance into Clinical Trials a Novel Treatment for PMM2-CDG, a Rare Glycosylation Disease Read More May 3, 2021 - Metavention Announces Initiation of Groundbreaking Multi-Organ Denervation Study Read More March 11, 2021 - CalciMedica Announces $21 Million Series D Financing Read More February 17, 2021 - Metavention Announces Initiation of U.S. Clinical Trial for Novel Treatment of Type 2 Diabetes Read More January 27, 2021 - ViaCyte Appoints Michael Yang President and CEO and Provides Company Update Read More January 25, 2021 - Chimerix Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares Read More January 8, 2021 - Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program Read More December 7, 2020 - Chimerix Announces FDA Acceptance of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox Read More May 21, 2020 - CalciMedica Announces that FDA Has Strongly Recommended Moving to a Blinded Placebo-controlled Trial with Auxora™ in Patients with Severe COVID-19 Pneumonia Read More January 8, 2020 - ViaCyte to Present at Biotech Showcase 2020 in San Francisco Read More